Switching to methadone: ’ad libitum‘ or ” xed dose ratio?

Abstract

Get full access to this article

View all access options for this article.

References

Tse DM , Sham MM , Ng DK , Ma HM . An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population. Palliat Med 2003; 17: 206–211.

Morley JS , Makin MF . Comments on Ripamonti. Pain 1997; 73: 114-114.

Gourlay GK , Plummer JL , Cherry DA , Cousins MJ . Does intravenous methadone provide longer lasting analgesia than intravenous morphine? Pain 1989; 42: 383–385.

Gourlay GK , Cherry DA , Cousins MJ . A comparative study of the ef” cacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 1986; 25: 297–312.

Mercadante S , Opioid rotation in cancer pain: rationale and clinical aspects. Cancer 1999; 86: 1856–1866.

Mercadante S , Casuccio A , Calderone L . Rapid switching from morphine to metadone in cacner patients with poor response to morphine. J Clin Oncol 1999; 17: 3307–3312.

Mercadante S , Casuccio A , Groff L , Bof” R , Villari P , Gebbia V , Ripamonti C . Switching from morphine to methadone to improve analgesia and tolerability in cancer patients — a prospective study. J Clin Oncol 2001; 19: 2898–2904.